Literature DB >> 32856339

Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions.

Majid Teymoori-Rad1, Sayed Mahdi Marashi1.   

Abstract

Evidence suggests that vitamin D supplementation could potentially be effective either in treatment or prevention of coronavirus disease 2019 (Covid-19). Indeed, several studies and trials have begun to investigate the impact of vitamin D supplementation on patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In this review, we focus on the potential mechanisms of vitamin D in the pathogenesis of Covid-19. We consider whether deficiency of vitamin D may be one of the underlying biological factors that could explain the excess mortality seen among non-Caucasians. We also raise several important questions which need to be addressed to provide a clear picture of the extent to which vitamin D supplementation may benefit patients with Covid-19, particularly those with underlying risk factors.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; Vitamin D; immune response

Mesh:

Substances:

Year:  2020        PMID: 32856339     DOI: 10.1002/rmv.2159

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  14 in total

Review 1.  COVID-19-related thyroid conditions (Review).

Authors:  Florica Șandru; Mara Carsote; Răzvan Cosmin Petca; Ancuta Augustina Gheorghisan-Galateanu; Aida Petca; Ana Valea; Mihai Cristian Dumitrașcu
Journal:  Exp Ther Med       Date:  2021-05-13       Impact factor: 2.447

Review 2.  Vitamin D Regulation of Immune Function.

Authors:  Daniel D Bikle
Journal:  Curr Osteoporos Rep       Date:  2022-05-04       Impact factor: 5.163

Review 3.  Diet, Probiotics and Their Impact on the Gut Microbiota during the COVID-19 Pandemic.

Authors:  Marzena Jabczyk; Justyna Nowak; Bartosz Hudzik; Barbara Zubelewicz-Szkodzińska
Journal:  Nutrients       Date:  2021-09-11       Impact factor: 6.706

4.  Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: An observational study.

Authors:  Sunali Padhi; Subham Suvankar; Venketesh K Panda; Abhijit Pati; Aditya K Panda
Journal:  Int Immunopharmacol       Date:  2020-09-14       Impact factor: 4.932

5.  Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study.

Authors:  Joaquim Oristrell; Joan Carles Oliva; Isaac Subirana; Enrique Casado; Didier Domínguez; Andrea Toloba; Patricia Aguilera; Joan Esplugues; Pilar Fafián; Maria Grau
Journal:  Biomedicines       Date:  2021-05-05

Review 6.  Micronutrient therapy and effective immune response: a promising approach for management of COVID-19.

Authors:  Fariba Lotfi; Mostafa Akbarzadeh-Khiavi; Ziba Lotfi; Leila Rahbarnia; Azam Safary; Habib Zarredar; Amir Baghbanzadeh; Behrooz Naghili; Behzad Baradaran
Journal:  Infection       Date:  2021-06-23       Impact factor: 7.455

7.  Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity.

Authors:  Nikola Kotur; Anita Skakic; Kristel Klaassen; Vladimir Gasic; Branka Zukic; Vesna Skodric-Trifunovic; Mihailo Stjepanovic; Zorica Zivkovic; Olivera Ostojic; Goran Stevanovic; Lidija Lavadinovic; Sonja Pavlovic; Biljana Stankovic
Journal:  Front Nutr       Date:  2021-06-04

8.  Bad Prognosis in Critical Ill Patients with COVID-19 during Short-Term ICU Stay regarding Vitamin D Levels.

Authors:  Lourdes Herrera-Quintana; Yenifer Gamarra-Morales; Héctor Vázquez-Lorente; Jorge Molina-López; José Castaño-Pérez; Juan Francisco Machado-Casas; Ramón Coca-Zúñiga; José Miguel Pérez-Villares; Elena Planells
Journal:  Nutrients       Date:  2021-06-09       Impact factor: 5.717

Review 9.  The role of vitamin D in reducing SARS-CoV-2 infection: An update.

Authors:  Mohammad Shah Alam; Daniel M Czajkowsky; Md Aminul Islam; Md Ataur Rahman
Journal:  Int Immunopharmacol       Date:  2021-04-17       Impact factor: 5.714

10.  Vitamin D supplementation and COVID-19 risk: a population-based, cohort study.

Authors:  J Oristrell; J C Oliva; E Casado; I Subirana; D Domínguez; A Toloba; A Balado; M Grau
Journal:  J Endocrinol Invest       Date:  2021-07-17       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.